| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/21/2007 | CA2631894A1 Novel trans-adjuvant system |
| 06/21/2007 | CA2631491A1 Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides |
| 06/21/2007 | CA2630839A1 Therapeutic methods for inhibiting tumor growth with dll4 antagonists |
| 06/21/2007 | CA2571886A1 Control of intestinal inflammatory syndromes with a preparation of killed or non infectious bacteria |
| 06/20/2007 | EP1798287A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798286A2 Mammalian cell membrane proteins and related reagents |
| 06/20/2007 | EP1798243A2 Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumors |
| 06/20/2007 | EP1798242A2 New anti-GF-IR antibodies and their applications |
| 06/20/2007 | EP1797898A1 Preventive/therapeutic drug for arteriosclerosis |
| 06/20/2007 | EP1797897A1 Medicinal composition containing meltrin antagonist |
| 06/20/2007 | EP1797896A1 Adjuvant systems and vaccines |
| 06/20/2007 | EP1797895A1 An adjuvant system comprising virosomes and liposomes |
| 06/20/2007 | EP1797894A2 Vaccine composition |
| 06/20/2007 | EP1797893A2 New composition |
| 06/20/2007 | EP1797886A2 Immune stimulation using chemically modified RNA |
| 06/20/2007 | EP1797877A1 Joint use of sulfonamide based compound with angiogenesis inhibitor |
| 06/20/2007 | EP1797432A2 Treating renal cell carcinoma with an anti-tnf human antibody or fragment |
| 06/20/2007 | EP1797200A2 Early detection of hemangiosarcoma and angiosarcoma |
| 06/20/2007 | EP1797189A2 Encapsidation system for production of recombinant virus-like particles |
| 06/20/2007 | EP1797182A2 Methods and compositions for improving recombinant protein production |
| 06/20/2007 | EP1797175A1 Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection |
| 06/20/2007 | EP1797173A2 Modulation of replicative fitness by using less frequently used synonymous codons |
| 06/20/2007 | EP1797126A1 Compositions monovalent for cd40l binding and methods of use |
| 06/20/2007 | EP1797125A2 Prevention and treatment of hcv infection employing antibodies directed against conformational and linear epitopes |
| 06/20/2007 | EP1797114A2 Cupredoxin derived transport agents and methods of use thereof |
| 06/20/2007 | EP1797113A1 Optimized vaccines to provide protection against ebola and other viruses |
| 06/20/2007 | EP1796735A2 Immunotherapy of autoimmune disorders |
| 06/20/2007 | EP1796723A2 Novel cancer associated antibodies and antigens and their use in cancer diagnosis |
| 06/20/2007 | EP1796722A1 Type i interferon blocking agents for prevention and treatment of psoriasis |
| 06/20/2007 | EP1796721A1 Cancerous disease modifying antibodies |
| 06/20/2007 | EP1796720A2 Multivalent avian influenza vaccines |
| 06/20/2007 | EP1796719A1 Refrigerator-temperature stable influenza vaccine compositions |
| 06/20/2007 | EP1796718A2 Therapeutic agents with decreased toxicity |
| 06/20/2007 | EP1796717A1 Combination vaccine |
| 06/20/2007 | EP1796699A1 Early childhood infection with human herpes virus type 6 (hhv-6) as a protection against the development of ige sensitization, atopic disease and allergy in young children. |
| 06/20/2007 | EP1796655A2 Use of modulators of a novel form of muscle selective calcineurin interacting protein (mcip-1-38) as a treatment for cardiovascular diseases |
| 06/20/2007 | EP1796652A2 Stabilization of alum-adjuvanted immunologically active agents |
| 06/20/2007 | EP1567653B1 Recombinant poxvirus comprising at least two cowpox ati promoters |
| 06/20/2007 | EP1472351B1 Amino acid sequences capable of facilitating penetration across a biological barrier |
| 06/20/2007 | EP1358353B1 Identification of genetic determinants of polymorphic cyp3a5 expression |
| 06/20/2007 | EP1281083B1 Methods for detecting inflammation and inflammatory conditions |
| 06/20/2007 | EP1274840B1 Ligand for herpes simplex virus entry mediator and methods of use |
| 06/20/2007 | EP1228231B1 Mammalian-type glycosylation in plants |
| 06/20/2007 | EP1159405B1 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 06/20/2007 | EP1056838B1 Method for the development of an hiv vaccine |
| 06/20/2007 | EP0789593B1 Yeast-based delivery vehicles |
| 06/20/2007 | CN1985169A Use of TWEAK modulators and inhibitors for the treatment of neurological conditions |
| 06/20/2007 | CN1985002A GM3 synthase as a therapeutic target in microvascular complications of diabetes |
| 06/20/2007 | CN1984999A Tolerance-induced targeted antibody production |
| 06/20/2007 | CN1984929A Methods for reducing biofilm formation in infectious bacteria |
| 06/20/2007 | CN1984680A Antibodies |
| 06/20/2007 | CN1984679A Methods for preparing immunogenic conjugates |
| 06/20/2007 | CN1984678A Immunogenic compositions for pneumonia chlamydia |
| 06/20/2007 | CN1984677A Truncated hepatitis C virus NS5 domain and fusion proteins comprising same |
| 06/20/2007 | CN1984676A Immunogenic peptide carrier conjugates and methods of producing same |
| 06/20/2007 | CN1984672A Modulation of NKG2D |
| 06/20/2007 | CN1984656A Cancer treatment method |
| 06/20/2007 | CN1984620A Bioactive bracket for type II diabetics and methods for use thereof |
| 06/20/2007 | CN1982459A Method of preparing mammal cell kinetin synthesis inhibitoroy factor |
| 06/20/2007 | CN1982355A Anti-microbial and oxidative co-polymer |
| 06/20/2007 | CN1982338A Neutralized monoclone antibody 4C13 of antiricin, its production and use |
| 06/20/2007 | CN1982332A Fusion protein of HIV regulatory/accessory proteins |
| 06/20/2007 | CN1981886A Nasal delivery devices |
| 06/20/2007 | CN1981868A Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma |
| 06/20/2007 | CN1981867A Specific effervescent tablet against candida albicans IgY |
| 06/20/2007 | CN1981866A DC vaccine for treating chronic hepatitis B |
| 06/20/2007 | CN1322134C Expression system |
| 06/20/2007 | CN1322127C BASB029 polynucleotide(s) and polypeptides from i(neisseria meningitidis) |
| 06/20/2007 | CN1322121C Hyaluronan synthase gene and uses thereof |
| 06/20/2007 | CN1322120C Bivalent hepatitis B-encephalitis B vaccine |
| 06/20/2007 | CN1322119C Mandarin fish rhabdo virus toxic strain, its preparation method and application |
| 06/20/2007 | CN1322009C Monoclonal antibody of virus receptor of anti leukoplakia disease and preparation method |
| 06/20/2007 | CN1322008C Monoclonal antibody of anti lymphocyst virus of and preparation method |
| 06/20/2007 | CN1322005C Constructs of branched synthetic peptide immunogens with artificial T helper cell epitopes coupled to B cell epitopes |
| 06/20/2007 | CN1321695C Antigen arrays presenting il-5, il-13 or eotaxin for treatment of allergic eosinophilic diseases |
| 06/20/2007 | CN1321694C Freezedrying type vaccine of AIDS recombined poxvirus with Ankara gene stock carrier, and preparation method |
| 06/20/2007 | CN1321693C Over-expressing homologous antigen vaccine and method of making same |
| 06/20/2007 | CN1321688C Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 06/19/2007 | US7232887 Melanoma antigens and their use in diagnostic and therapeutic methods |
| 06/19/2007 | US7232684 DNA encoding hyaluronan synthase from Pasteurella multocida and methods of use |
| 06/19/2007 | US7232682 Expression vectors encoding epitopes of target-associated antigens and methods for their design |
| 06/19/2007 | US7232680 For producing vaccine for protecting a mammal or a bird from infection by a Nidovirales virus |
| 06/19/2007 | US7232571 Or Sporolactobacillus; also decreasing serum triglycerides, and increasing serum HDL; optionally along with an anticholesterol agent such as a statin, a bile sequestering compound, a fiber product capable of binding cholesterol, niacin or aspirin. |
| 06/19/2007 | US7232569 Type III secretion pathway in aeromonas salmonicida, and uses therefor |
| 06/19/2007 | US7232568 Compositions and methods for treating hyperimmune response in the eye |
| 06/19/2007 | US7232566 Methods for treating HIV infected subjects |
| 06/19/2007 | US7232563 A fusion proteins having the C-terminal region of the interfero protein is replaced by a C-terminal region of tau proteins; viricides, antiproliferation agents, antiinflammatory agents; lower cytotoxic side effects |
| 06/19/2007 | US7232562 E38N interferon gamma polypeptide variants |
| 06/19/2007 | CA2185826C Peptide fragments of microbial stress proteins and pharmaceutical composition made thereof for the treatment and prevention of inflammatory diseases |
| 06/19/2007 | CA2159112C Anti-microbial agents and screening method therefor |
| 06/19/2007 | CA2073124C Tumor antigen specific antibody |
| 06/19/2007 | CA2066738C Prevention, treatment and amelioration of a pathology characterized by brain inflammation |
| 06/19/2007 | CA2013582C Method for enhancing transmembrane transport of exogenous molecules |
| 06/16/2007 | CA2557055A1 Peptides for stimulating an immune response against melanoma |
| 06/14/2007 | WO2007067976A2 Method of using il6 antagonists with proteasome inhibitors |
| 06/14/2007 | WO2007067959A2 Ctla-4 antibody dosage escalation regimens |
| 06/14/2007 | WO2007067808A2 Immunogenic composition based on conditionally live virion and method for producing the same |
| 06/14/2007 | WO2007067780A2 Combination therapy and antibody panels |
| 06/14/2007 | WO2007067744A2 Method for assembling a polymer-biologic delivery composition |
| 06/14/2007 | WO2007067729A2 Microbial vaccine and vaccine vector |